Epstein RL, Wang J, Hagan L, et al. - Researchers investigated hepatitis C virus (HCV) testing and the HCV care cascade among 13- to 21-year-olds accessing US federally qualified health centers (FQHCs), a significant healthcare source for underserved communities. In the United States, HCV incidence has increased with people younger than 30 years who inject drugs exhibiting most new transmissions. Reports of chronic HCV infections have increased among 15 to 24-year-olds; these have risen from 3.8% in 2009 to 9.1% in 2013-2016. HCV testing and linkage to care are identified as crucial steps toward eliminating HCV. As per current guidance, HCV testing is recommended for children or adults with HCV risk, including anyone who has injected drugs, the most frequently identified risk factor.